Resmed (RMD) Shares Outstanding (2010 - 2026)

Resmed has reported Shares Outstanding for 17 years, with the latest figure at $145.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding changed 0.39% year-over-year to $190.9 million; the trailing twelve-month figure through Mar 2026 stood at $190.9 million (changed 0.39% YoY), and the FY2025 full-year result was $146.4 million, down 22.78% from the prior year.
• Shares Outstanding for Q1 2026 stood at $190.9 million, roughly flat from $190.8 million in the prior quarter.
• The five-year high for Shares Outstanding was $190.9 million in Q1 2026, with the low at -$41.8 million in Q1 2022.
• Historically, Shares Outstanding has averaged $173.3 million across 5 years, with a median of $189.3 million in 2023.
• Annual changes were most pronounced in 2022 — Shares Outstanding slumped 122.33% — and 2023, when it surged 551.19%.
• Resmed's Shares Outstanding stood at $188.7 million in 2022, then rose by 0.28% to $189.3 million in 2023, then increased by 0.42% to $190.0 million in 2024, then grew by 0.4% to $190.8 million in 2025, then gained by 0.03% to $190.9 million in 2026.
• The last three Shares Outstanding figures came in at $190.9 million (Q1 2026), $190.8 million (Q4 2025), and $190.4 million (Q3 2025), per Business Quant data.